Efficacy and Safety of Teicoplanin in CDAD

NCT04003818 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class

Stopped Due to COVID-19 and great challenges during patient enrolment period, current status of this study is far behind the plan. The study cannot be completed according to the plan. Sanofi decides to terminate the study upon comprehensive assessment.

Conditions

Interventions

Sponsor

Sanofi